Contact Us HOME
go to Japanese version
NEWS RELEASE
2014.10.09 Notice of launch of the FCeM®Series, a new three-dimensional culture for cancer cells
2014.09.24 Change of Research Organization
2014.07.29 Notice of Revision of Forecasts
2014.07.29 Presentation materials for 1Q FY2014
2014.07.29 Financial Results for the 1st Quarter of FY2014
2014.07.22 Development of room temperature gelling stretchable hydrogel AQUAJOINT
2014.06.18 Revision of Consolidated Financial Results for the Fiscal Year Ended March 31, 2014(From April 1, 2013 to March 31, 2014)
2014.06.05 Japan Chemical Industry Association RC Grand Prix Award Received
-The 8th Annual Responsible Care Award-
2014.06.02 Bringing patent infringement actions in the United States concerning drug applications of generic drugs of “LIVALO®,” a therapeutic agent for hypercholesterolemia
2014.05.27 Marketing License of Bravecto, Veterinary Medical Product in the USA
2014.05.15 Presentation material for FY2013(From April 1, 2013 to March 31, 2014)
2014.05.15 Consolidated Financial Results for the Fiscal Year Ended March 31, 2014(From April 1, 2013 to March 31, 2014)
2014.05.15 Notice of Resolution on Dividend Payment
2014.04.30 Discontinuation of the license agreement for a new therapeutic agent for thrombocytopenia
2014.04.25 A 3D sphere culture system containing functional polymers for large-scale human pluripotent stem cell production
2014.04.04 President's Address at Company Initiation Ceremony
(summarized version)
2014.03.13 Notice Regarding Cancellation of Treasury Shares
2014.03.12 Notice Regarding Market Purchase of the Company’s Own Shares and Completion of Acquisition
2014.03.05 Bringing patent infringement actions concerning generic drugs of “LIVALO,” a therapeutic agent for hypercholesterolemia (the fourth report)
2014.02.18 Sales of Fluralaner, active substance of Veterinary Medical Product
2014.02.18 Notice on Partial Amendment to the Articles of Incorporation
2014.02.18 Introduction of the Executive Officer System and Changes of Directors
2014.02.14 Notice regarding to establish affiliate company in People’s Republic of China
2014.02.14 Bringing patent infringement actions concerning generic drugs of “LIVALO,” a therapeutic agent for hypercholesterolemia (the third report)
2014.02.04 Notice Regarding Purchase of the Company's Own Shares
2014.02.04 Presentation materials for 3Q FY2013
2014.02.04 Financial Results for the 3rd Quarter of FY2013
2014.01.16 Bringing patent/trademark infringement actions concerning generic drugs of “LIVALO,” a therapeutic agent for hypercholesterolemia
(the second report)
2014.01.16 Notice of Nissan Chemical Group Welfare Fund Activity
2013.12.26 Bringing patent infringement actions concerning generic drugs of "LIVALO", a therapeutic agent for hypercholesterolemia
2013.12.10 CSR Report 2013
2013.11.26 Release of "ReproHSC", a new medium for hematopoietic stem cell
2013.10.29 Presentation material for 1H FY2013(April 1, 2013 to September 30,2013)
2013.10.29 Financial Results for 1H FY2013(April 1, 2013 to September 30,2013)
2013.10.29 Revision of Forecast and Resolution on Interim Dividend Payment for FY2013
2013.09.26 Regarding Merger of Pharmaceuticals Division and Custom Chemicals Group
2013.09.18 IR presentation for 2013 Mizuho Investment Conference
2013.08.30 IR presentation for Mizuho Pan-Asia Corporate Day 2013
2013.08.28 Announcement Regarding a Pharmaceutical (Notice)
TOPICS
HYPERTECH® Website opens.
Pharmaceutical Intermediates, APIs-Custom Synthesis Service
 

CORPORATE PROFILE
Message from the president
Corporate Summary
History
Organization
Network
Nissan Chemical Group
Research and Development
CSR Report

BUSINESSES
Chemicals
Basic Chemicals
Fine Chemicals
Performance Materials
Display Materials
Semiconductor Materials
Inorganic Materials
Agricultural Chemicals
Pharmaceuticals
Advanced Materials

FOR INVESTORS
IR Library
Annual Report
Financial Highlight
Medium-Term Business Plan
Vista 2015
Ratings Information
Site Map